In Response

Affiliations

Comment

Clemens R M Barends et al. Anesth Analg. 2021.

. 2021 May 1;132(5):e77.

doi: 10.1213/ANE.0000000000005438.

¹ Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands, c.r.m.barends@umcg.nl.

No abstract available

Comment on

Moderate-to-Deep Sedation Using Target-Controlled Infusions of Propofol and Remifentanil: Adverse Events and Risk Factors: A Retrospective Cohort Study of 2937 Procedures.
Barends CRM, Driesens MK, van Amsterdam K, Struys MMRF, Absalom AR. Barends CRM, et al. Anesth Analg. 2020 Oct;131(4):1173-1183. doi: 10.1213/ANE.0000000000004593. Anesth Analg. 2020. PMID: 32925338
Sedation Safety and Satisfaction.
Nielsen JR. Nielsen JR. Anesth Analg. 2021 May 1;132(5):e76. doi: 10.1213/ANE.0000000000005437. Anesth Analg. 2021. PMID: 33857993 No abstract available.

1. Nielsen JR. Sedation safety and satisfaction. Anesth Analg. 2021;132:e76.
1. Barends CRM, Driesens MK, van Amsterdam K, Struys MMRF, Absalom AR. Moderate-to-deep sedation using target-controlled infusions of propofol and remifentanil: adverse events and risk factors: a retrospective cohort study of 2937 procedures. Anesth Analg. 2020;131:1173–1183.